CD276 and neoplasm: In severe combined immunodeficient (SCID) mice, tumors derived from B7H3-deficient 4T1 cells re-expressing B7H3-WT and those derived from cells re-expressing B7H3-4NQ exhibited no significant changes in tumor burden, as confirmed by the growth curve of the xenograft tumor volume and the tumor weight (Fig. 4e).